Raising Medicare Age to 67 Would Increase Out-of-Pocket by $5.6B

Advertisement

Raising the eligibility age for Medicare from 65 to 67 in 2014 would save the federal government $7.6 billion in 2014 but would increase out-of-pocket costs for dropped beneficiaries by approximately $5.6 billion, according to release by the Kaiser Family Foundation.

The higher age limit, suggested by several recent deficit-reduction plans, would also increase the number of the uninsured and raise state Medicaid expenditures by $700 million, the Kaiser study found.

In addition, the change would raise premiums by 3 percent for the remaining Medicare beneficiaries, who would be older and have a greater need for medical services. Conversely, the arrival of 65- to 67-year-olds, who have a relatively greater need for medical services than younger people, in the new insurance exchanges planned under healthcare reform would raise premiums for everybody in the exchanges by 3 percent.

While most beneficiaries ages 65-66 would have higher out-of-pocket spending outside of Medicare, the Kaiser study found that almost one in four would actually have lower out-of-pocket spending, but only if health reform stayed in place.

Read the Kaiser Family Foundation release on Medicare coverage.

Read more coverage of plans to alter Medicare eligibility:

– Federal Deficit Panel’s Draft Report Includes Fee-Fix, Cuts for Hospitals

– Federal Debt Panel Proposes 20 Major Cuts for Hospitals, Physicians

– Separate Deficit Panel Releases Report, Pushes More Costs Onto Medicare Beneficiaries

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Public Health

Advertisement

Comments are closed.